Outsourcing

Articles

The contract research organization has increased its US-based early phase clinical capacity and doubled its specialty lab space.

QPS Expands US-Based Phase I Clinical Trial Capabilities

ADC Biotechnology will invest downstream formulation, fill/finish capabilities, and Lock-Release conjugation technology.

ADC Bio Secures Additional Equity Round Investment

With the $252-million acquisition of contract development, manufacturing, and testing organization Avista Pharma Solutions, Cambrex will enter the market for early stage small-molecule development and testing services.

Cambrex to Acquire Avista Pharma

In preparation for the upcoming US Drug Supply Chain Security Act deadline, Metrics Contract Services has expanded serialization capabilities at its oral solid-dose commercial manufacturing site in Greenville, NC.

Metrics Adds Serialization Capabilities to North Carolina Site

Experts believe that the contract development and manufacturing organization market will reach $17.38 billion by 2022, with disruptive business models using Industrial Internet of Things (IIot) and single-use technologies proving more profitable and efficient in the long term.

Single-use and IIoT Solutions Expected to Reduce Costs and Enhance Production Efficiency

Pharmatech Associates International Contracting and Services is a new company headquartered in Doha, Qatar, that will provide product development, facility design, and construction for high quality pharmaceutical and biotech products at low cost.


Pharmatech Associates Launches International Contracting and Services Company

Idifarma, a contract development and manufacturing organisation (CDMO), based in Spain, has announced the commencement of the seventh project with Palobiofarma-a Spanish biotechnology company.

Spanish CDMO, Idifarma, Begins Seventh Project with Biotechnology Company

The contract development and manufacturing organization released its first serialized products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden.

Recipharm Releases First Serialized Products to Europe

The new facility will include comprehensive mammalian process development and manufacturing capabilities.

AGC Biologics Adds Mammalian Production Capacity in Japan

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

Industry experts discuss the formulation and development issues that should be considered when addressing scale up from small-scale batches to commercial production.

Contract Development Services